The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from other disease indications. Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program advances Parkinson’s disease therapeutic and intervention development along the pre-clinical and clinical path.
Applications should focus on studies in one or more of the following areas:
- rotection or restoration of degenerating and/or dysfunctional neurons affected in Parkinson’s
- Alleviation of disabling motor or non-motor symptoms of Parkinson’s not well managed by current treatments
- Reduction of complications and side effects of current Parkinson’s treatments.
For more informations viste the webiste page: Therapeutic Pipeline Program
Awards: up to $500,000 for one-two-year pre-clinical grants
up to $2 million for two-three year pre-clinical grants
Deadline for pre-proposals: May 14, 2020
Full proposals (by invite only): September 22, 2020